Bruno Gomes

962 total citations
38 papers, 422 citations indexed

About

Bruno Gomes is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bruno Gomes has authored 38 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Immunology. Recurrent topics in Bruno Gomes's work include Cancer Immunotherapy and Biomarkers (7 papers), Transplantation: Methods and Outcomes (6 papers) and Immunotherapy and Immune Responses (5 papers). Bruno Gomes is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Transplantation: Methods and Outcomes (6 papers) and Immunotherapy and Immune Responses (5 papers). Bruno Gomes collaborates with scholars based in Canada, Switzerland and France. Bruno Gomes's co-authors include Isabelle Vandenberghe, Nicolas Guilbaud, Anna Kruczynski, Laurent Créancier, Laurence Lamant, Jean Edouard Gairin, Joëlle Riond, Nicolás Meyer, Janick Sèlves and Rosine Guimbaud and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Bruno Gomes

37 papers receiving 416 citations

Peers

Bruno Gomes
Lucas Fass United States
Shan K. Naidu United States
Sherianne Ricks United States
Kyeongmin Kim South Korea
J. Carmichael United Kingdom
Lucas Fass United States
Bruno Gomes
Citations per year, relative to Bruno Gomes Bruno Gomes (= 1×) peers Lucas Fass

Countries citing papers authored by Bruno Gomes

Since Specialization
Citations

This map shows the geographic impact of Bruno Gomes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Gomes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Gomes more than expected).

Fields of papers citing papers by Bruno Gomes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Gomes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Gomes. The network helps show where Bruno Gomes may publish in the future.

Co-authorship network of co-authors of Bruno Gomes

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Gomes. A scholar is included among the top collaborators of Bruno Gomes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Gomes. Bruno Gomes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Bruno, et al.. (2025). Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder. The AAPS Journal. 27(1). 30–30. 1 indexed citations
2.
Benzekry, Sébastien, Abdessamad El Kaoutari, Bruno Gomes, et al.. (2024). Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre‐ and on‐Treatment Prognostic Biomarkers. Clinical Pharmacology & Therapeutics. 116(4). 1110–1120. 6 indexed citations
3.
Reis, Bernhard, et al.. (2024). Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers. Frontiers in Immunology. 15. 1285049–1285049. 7 indexed citations
4.
Brennan, Laura, Jurriaan Brouwer‐Visser, Eveline Nüesch, et al.. (2022). T-Cell Heterogeneity in Baseline Tumor Samples: Implications for Early Clinical Trial Design and Analysis. Frontiers in Immunology. 13. 760763–760763. 2 indexed citations
5.
Ribeiro, Rafaela Vanin Pinto, J.A. Álvarez, F. Yu, et al.. (2021). Assessment of Cerebral Perfusion and Activity during Normothermic Regional Perfusion in a Porcine Model of Donation after Circulatory Death. The Journal of Heart and Lung Transplantation. 40(4). S234–S234. 8 indexed citations
6.
McFadden, Christopher B., Bruno Gomes, Rafaela Vanin Pinto Ribeiro, et al.. (2021). Determination of Optical Properties and Photodynamic Threshold of Lung Tissue for Treatment Planning of In Vivo Lung Perfusion Assisted Photodynamic Therapy. Photodiagnosis and Photodynamic Therapy. 35. 102353–102353. 9 indexed citations
7.
Caudell, David L., et al.. (2021). 11 Molecular characterization of naturally occurring colorectal and breast cancer in non-human primates to model human immunotherapeutic agents. SHILAP Revista de lepidopterología. A11–A11. 1 indexed citations
8.
Failmezger, Henrik, Chia-Huey Ooi, Derrek P. Hibar, et al.. (2020). Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer—A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research. Frontiers in Immunology. 11. 550250–550250. 18 indexed citations
9.
Ribeiro, Rafaela Vanin Pinto, Jorge Santana Álvarez, Bruno Gomes, et al.. (2020). Assessment of Cerebral Perfusion and Activity during Normothermic Regional Perfusion in a Porcine Model of Donation after Circulatory Death. The Journal of Heart and Lung Transplantation. 39(4). S352–S352. 2 indexed citations
10.
Ramadan, Khaled, Bruno Gomes, M. Pipkin, et al.. (2020). A model to assess acute and delayed lung toxicity of oxaliplatin during in vivo lung perfusion. Journal of Thoracic and Cardiovascular Surgery. 161(5). 1626–1635. 7 indexed citations
11.
Gomes, Bruno, Rafaela Vanin Pinto Ribeiro, Jorge Santana Álvarez, et al.. (2020). Normothermic Regional Perfusion (NRP) during Heart DCD Recovery: Is Lung Quality Impacted? A Pre-Clinical Study. The Journal of Heart and Lung Transplantation. 39(4). S353–S354. 5 indexed citations
12.
Ait-Belkacem, Rima, et al.. (2019). Target exposure and pharmacodynamics study of the indoleamine 2,3-dioxygenase-1 (IDO-1) inhibitor epacadostat in the CT26 mouse tumor model. Journal of Pharmaceutical and Biomedical Analysis. 170. 220–227. 8 indexed citations
13.
Larminat, Florence, Dennis Gómez, Philippe Frit, et al.. (2017). The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks. Molecular Cancer Therapeutics. 16(10). 2166–2177. 6 indexed citations
15.
Pillon, Arnaud, Bruno Gomes, Isabelle Vandenberghe, et al.. (2017). Actinic keratosis modelling in mice: A translational study. PLoS ONE. 12(6). e0179991–e0179991. 10 indexed citations
16.
Ait-Belkacem, Rima, Vanesa Bol, Grégory Hamm, et al.. (2017). Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology. SLAS DISCOVERY. 22(10). 1182–1192. 22 indexed citations
17.
Créancier, Laurent, Isabelle Vandenberghe, Bruno Gomes, et al.. (2015). Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma. Cancer Letters. 365(1). 107–111. 71 indexed citations
18.
Rahier, Nicolas J., Christophe Long, S. K. Deshmukh, et al.. (2015). Anticancer activity of koningic acid and semisynthetic derivatives. Bioorganic & Medicinal Chemistry. 23(13). 3712–3721. 29 indexed citations
19.
Kruczynski, Anna, Arnaud Pillon, Laurent Créancier, et al.. (2013). F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity. Leukemia. 27(11). 2139–2148. 30 indexed citations
20.
Riond, Joëlle, Isabelle Vandenberghe, Bruno Gomes, et al.. (2012). Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells. PLoS ONE. 7(5). e36762–e36762. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026